NASDAQ$PLL
Piedmont Lithium Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Piedmont Lithium reported Q2 2024 results, achieving steady-state production at NAL and shifting shipments to contract customers.
Piedmont Lithium reported Q2 2024 financial results, with revenue of $13.2 million from sales of approximately 14,000 dmt of spodumene concentrate. NAL achieved steady-state production in June 2024, with record quarterly production, lithium recovery, and mill utilization.
- NAL set quarterly records in Q2 2024 for production (up 23% QoQ), lithium recovery (68%), and mill utilization (83%).
- NAL achieved steady-state production in June 2024; H2 2024 production forecast supports Piedmont shipping guidance.
- Piedmont revenue of $13.2 million on sales of approximately 14,000 dmt of spodumene concentrate in Q2 2024.
- Carolina Lithium mining permit received in Q2 2024 from the state of North Carolina, renewing funding discussions.
Headline financials
Revenue & EPS history
Piedmont Lithium · Revenue · Quarterly
$13.2M
Forward guidance
Piedmont expects to ship approximately 96,500 dmt of spodumene concentrate in H2 2024. Capital allocations and investments in affiliates are anticipated to be modest given the completion of the NAL ramp-up and expected timing of Ewoyaa development.
Tailwinds
- NAL achieved full run-rate production in June 2024.
- Piedmont has the right to purchase the greater of 50% of production or 113,000 dmt/year under its offtake agreement with Sayona Quebec.
- Piedmont expects to ship approximately 126,000 dmt of spodumene concentrate in 2024.
- Piedmont is targeting approximately 96,500 dmt of spodumene concentrate shipments in H2 2024; forecasted NAL production supports the shipping guidance.
- We are prioritizing contract customer shipments and structuring spot shipments to limit downside exposure.
Headwinds
- Quarterly shipping targets are rounded to the nearest thousand tons and may not total to 126,000 dmt due to rounding.
- A shipment totaling approximately 14,000 dmt was delayed from late Q2 2024 to early Q3 2024.
- Our outlook for forecasted capital expenditures and investments in and advances to affiliates is subject to market conditions.
- Approvals at Ewoyaa are ongoing.
- We expect modest capital expenditures in H2 2024, mainly related to Carolina Lithium.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports · overlaid with Q2 2024
-1.7%
Avg return
Earnings day
+0.2%
Avg return
5 days after
-12.9%
Avg return
30 days after
59%
10 / 17 earnings
Positive
+9.9%
Q3 2024
Best reaction
-26.7%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | +2.5% | +10.7% | — | |
| Q1 2025 | +2.8% | -1.3% | -12.5% | |
| Q4 2025 | +3.7% | -6.1% | -13.0% | |
| Q3 2024 | +9.9% | -3.8% | -5.8% | |
| Q2 2024 | -7.3% | -12.2% | -25.2% | |
| Q1 2024 | +0.7% | +19.2% | -7.6% | |
| Q4 2023 | -13.9% | -5.0% | -13.6% | |
| Q3 2023 | +0.5% | — | — | |
| Q2 2023 | -3.8% | — | — | |
| Q1 2023 | +9.1% | — | — | |
| Q4 2022 | -3.6% | — | — | |
| Q3 2022 | +0.2% | — | — | |
| Q2 2022 | +3.6% | — | — | |
| Q1 2022 | -26.7% | — | — | |
| Q4 2021 | +1.1% | — | — | |
| Q1 2021 | -2.1% | — | — | |
| Q2 2021 | -4.6% | — | — | |
| Q2 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro